09.24.2026
FDA Approves Rayner’s RayOne Galaxy Spiral IOL Platform
Rayner announced FDA approval and US commercial availability of its RayOne Galaxy and RayOne Galaxy Toric IOLs, bringing the company’s spiral optic platform to US cataract surgeons. The US launch follows more than 200,000 implantations across 75 countries since the platform’s international introduction in 2024, according to the company.